Pharma’s digital transformation is about value—here’s where to find it

Acting now could be worth billions in operating income for any big pharmaceutical company.

In this analysis, ZS shares seven digital programs that have proven to be top value creators in clinical development, commercial engagement and supply chain and manufacturing.

These programs are the operational powerhouses that can readily scale across large multinational organizations, supported by existing technology, data, and AI and analytics foundations.

They’re for any digital and technology leader driving digital breakthroughs into more extensive portfolios of business processes or across therapies and markets.

From this piece, you’ll be able to create a compelling value story for the enterprise, test your company’s ability to create business value and recommit to scaling proven programs.